Simcere Pharmaceutical Group is a pharmaceutical company based in Nanjing, China. It develops, manufactures and markets medicines, with a focus on generic and branded prescription drugs. Its products serve hospitals and patients in China and cover areas such as central nervous system conditions, oncology and infectious disease. The company also works on innovative drug research alongside its established portfolio of treatments.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 2096, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #723 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendFair
69/100
Mixed trend against its averages.
See the numbers →
Above 200-day average-5.3%
From 52-week high-20.3%
MomentumWeak
42/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-16.9%
6-month return-19.0%
12-month, skipping last month-8.8%
Stability (higher is calmer)Strong
73/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)41.7%
Worst drawdown, 1 year (smaller is calmer)-32.6%
LiquidityStrong
88/100
Trades actively.
See the numbers →
Avg daily value traded60.18M HKD
Zero-volume days0.0%
IncomeWeak
37/100
Dividend is small or irregular.
See the numbers →
Dividend yield1.9%
Years with dividends5
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 9.07 – 14.08Daily closes, split-adjusted
Signals
50-day average11.51
200-day average11.56
Golden/death cross (60d)Death, 2 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.40
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
11.01
Bearish
EMA 10
11.01
Bearish
SMA 20
11.24
Bearish
EMA 20
11.16
Bearish
SMA 50
11.51
Bearish
EMA 50
11.38
Bearish
SMA 100
11.31
Bearish
EMA 100
11.48
Bearish
SMA 200
11.56
Bearish
EMA 200
11.48
Bearish
Oscillators (daily)
RSI (14)
43.12
Neutral
MACD (12, 26)
-0.18
Bearish
Momentum (12)
-7.68
Bearish
Stochastic %K (14)
31.65
Neutral
Williams %R (14)
-68.35
Neutral
CCI (20)
-62.67
Neutral
Pivot points (classic, last session)
S3
10.46
S2
10.66
S1
10.80
Pivot
11.00
R1
11.14
R2
11.34
R3
11.48
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.21 HKD
Yield on today's price
1.89%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
17 Jun 2026
0.2069
18 Jun 2025
0.1748
18 Jun 2024
0.1757
19 Jun 2023
0.1758
28 Jun 2022
0.1757
29 Jun 2021
0.1803
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
